CBD Market in the US Expected to Reach $20.4 Billion by 2023

Mar.04.2023
CBD Market in the US Expected to Reach $20.4 Billion by 2023
This article is about the growth of the CBD industry in the US market and its potential global impact.

Statement:


This article is limited to conducting research on the related industries and overseas markets, and does not make recommendations for any products or provide comments on any domestic policies.


The legality of the products mentioned in the article is only limited to overseas areas. Domestic readers are advised to take note and strictly comply with relevant laws and regulations of China.


This article does not constitute any investment or consumer advice.


This article is not suitable for minors to read.


On the morning of March 3rd, Eastern Time, two employees from the Washington News Center of 2FIRSTS interviewed Caesar, their marketing manager, at the APE exhibition. Caesar stated that the CBD market in the United States is expected to reach $20.4 billion by 2023.


During an interview with 2FIRSTS, Caesar revealed that APE has noticed a significant increase in sales of CBD products at recent exhibitions. He noted that compared to the tobacco industry and other related industries, the growth in CBD sales is much more substantial. It is projected that the CBD market in the United States will reach $20.4 billion by the year 2023, as stated by Caesar.


Caesar stated that the use of CBD is becoming increasingly widespread. Currently, many companies have started to incorporate CBD in food and drink products, such as butter, oil, or other grains.


Caesar announced that their next exhibition will be held in Medellin, South America. Over 90% of the exhibition spaces have already been sold. The exhibition in Dallas, USA, sold out 70% of its spaces within five months after the show.


Furthermore, Caesar told 2FIRSTS that APE was formerly known as the USA CBD Expo, but due to the growth of e-cigarettes, the USA CBD Expo had to add e-cigarette categories, thus evolving into the Alternative Products Expo.


Further reading:


The media company 2FIRSTS has been named the official partner of the APE Expo, a tobacco trade show in the United States. As a result, they will provide comprehensive coverage of the event.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Austria to Tighten Sales Rules for Nicotine Pouches and E-Liquids From April 1
Austria to Tighten Sales Rules for Nicotine Pouches and E-Liquids From April 1
Austria will introduce new sales rules for nicotine products from April 1, 2026. Under a reform of the tobacco law passed in December 2025, nicotine pouches will in future be sold only through tobacco shops, while e-liquids will be sold only through tobacco shops and licensed specialist stores. Other points of sale will no longer be permitted to sell these products.
Mar.30 by 2FIRSTS.ai
BAT France Confirms Full Compliance as France Implements Nicotine Pouch Ban on April 1from April 2026
BAT France Confirms Full Compliance as France Implements Nicotine Pouch Ban on April 1from April 2026
BAT France said that, under the decree of September 5, 2025 that entered into force on April 1, 2026, it has stopped commercialising its nicotine pouch products in France from that date.
Apr.03 by 2FIRSTS.ai
FDA Filing Shows RIF Notices for 229 CTP Employees Were Largely Rescinded
FDA Filing Shows RIF Notices for 229 CTP Employees Were Largely Rescinded
A court declaration signed by FDA official Melanie M. Keller on March 24, 2026 detailed the status of previously issued reduction-in-force notices affecting employees at the Center for Tobacco Products (CTP).
Apr.01 by 2FIRSTS.ai
Ispire Reports Fiscal Q3 2026 Revenue of $18.7 Million and Net Loss of $9.5 Million
Ispire Reports Fiscal Q3 2026 Revenue of $18.7 Million and Net Loss of $9.5 Million
Ispire Technology reported financial results on May 7, 2026, for the third quarter of fiscal 2026, covering the three months ended March 31, 2026. Revenue was $18.7 million, compared with $26.2 million in the third quarter of fiscal 2025 and $20.3 million in the prior quarter. Gross profit was $2.0 million, with gross margin of 10.7%. Net loss was $9.5 million, or $0.17 per share. The company said it held $18.0 million in cash as of March 31, 2026, up $468,000 sequentially.
May.08 by 2FIRSTS.ai
FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
The U.S. Food and Drug Administration (FDA) announced on May 5, 2026 that it authorized the marketing of four Glas electronic nicotine delivery system (ENDS) products through the premarket tobacco product application (PMTA) pathway. The authorized products are Classic Menthol, Fresh Menthol, Gold and Sapphire pods, each containing 50mg/ml, or 5%, tobacco-derived nicotine.
May.06 by 2FIRSTS.ai
UK Opens Applications for Vaping Products Duty and Duty Stamps Scheme From April 1
UK Opens Applications for Vaping Products Duty and Duty Stamps Scheme From April 1
HM Revenue and Customs announced that from April 1, 2026, UK vaping product manufacturers, importers and warehousekeepers can apply for approval under Vaping Products Duty (VPD) and the Vaping Duty Stamps Scheme (VDS). Under new GOV.UK guidance, Vaping Products Duty will take effect on October 1, 2026 and will apply to all vaping liquids, whether they contain nicotine or not.
Apr.02 by 2FIRSTS.ai